The decision to end the model designs, which concern formulary changes and removal of downside risk for 2022, came after stakeholder feedback.
The Part D Payment Modernization Model will continue to test out two-sided risk models for the 2022 calendar year, CMS said.
Read more here.
More articles on payers:
MDLive deal, telehealth: What Cigna’s Evernorth COO envisions
Aetna barred from seeking alleged hospital overpayments linked to Mednax billing
13 payer exec moves
